Publications by authors named "Johan Liwing"

Claim this Profile
C
Cardiovascular, bone, and metabolic health in men with castrate-resistant prostate cancer treated with androgen deprivation: a matched cohort study.
Yashar Khoshkar, Hari T Vigneswaran, Sandra Eloranta, Therese M-L Andersson, Frida Schain, Johan Liwing

Acta Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma.
Hareth Nahi, Michael Chrobok, Stephan Meinke, Charlotte Gran, Nicole Marquardt, Johan Liwing

Cell Rep Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involved free light chain: an early independent predictor of response and progression in multiple myeloma.
Charlotte Gran, Gabriel Afram, Johan Liwing, Andre Verhoek, Hareth Nahi

Leuk Lymphoma· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world treatment utilization patterns in patients with castration-resistant prostate cancer.
Hari T Vigneswaran, Anna Warnqvist, Therese M L Andersson, Amy Leval, Martin Eklund, Johan Liwing

Scand J Urol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Alignment of Real-World Evidence and Digital Health: Realising the Opportunity.
Sajan Khosla, Maurille Feudjo Tepie, Mark J Nagy, George Kafatos, Michael Seewald, Johan Liwing

Ther Innov Regul Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression.
Charlotte Gran, Vincent Luong, Johanna B Bruchfeld, Johan Liwing, Gabriel Afram

Am J Hematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease.
Frida Schain, Nurgul Batyrbekova, Johan Liwing, Simona Baculea, Thomas Webb

Eur J Health Econ· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging the Gap Between RCTs and RWE Through Endpoint Selection.
Robert J LoCasale, Chris L Pashos, Ben Gutierrez, Nancy A Dreyer, Toby Collins, Johan Liwing

Ther Innov Regul Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma.
Charlotte Gran, Johan Liwing, Arnika Kathleen Wagner, Andre Verhoek, Ana Gezin

Am J Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Bridging the Gap Between RCTs and RWE Through Endpoint Selection.
Robert J LoCasale, Chris L Pashos, Ben Gutierrez, Nancy A Dreyer, Toby Collins, Johan Liwing

Ther Innov Regul Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden.
Markus Aly, Amy Leval, Frida Schain, Johan Liwing, Joe Lawson

Scand J Urol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strengthening pharma's contract with society: the value of trusted partnerships between pharma and healthcare facilitated by real-world data.
Michael J Seewald, Jonathan M Plumb, Ben Gutierrez, Johan Liwing, Maurille Feudjo Tepie

J Comp Eff Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes in myelofibrosis patients treated with ruxolitinib: A population-based cohort study in Sweden and Norway.
Frida Schain, Emese Vago, Ci Song, Jianming He, Johan Liwing

Eur J Haematol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-to-event Outcomes in Men with Nonmetastatic Castrate-resistant Prostate Cancer-A Systematic Literature Review and Pooling of Individual Participant Data.
Markus Aly, Mahmoud Hashim, Bart Heeg, Johan Liwing, Amy Leval

Eur Urol Focus· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment.
Katarina Uttervall, Adil D Duru, Johan Lund, Johan Liwing, Gösta Gahrton

PLoS One· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population.
Johan Liwing, Katarina Uttervall, Johan Lund, Anders Aldrin, Cecilie Blimark

Br J Haematol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma--a retrospective population based study of 1162 patients.
Johan Lund, Katarina Uttervall, Johan Liwing, Gösta Gahrton, Evren Alici

Eur J Haematol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of algorithms for oral busulphan area under the concentration-time curve limited sampling estimate.
Fredrik Sjöö, Ibrahim El-Serafi, Jon Enestig, Jonas Mattsson, Johan Liwing

Clin Drug Investig· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination regimen of bortezomib, cyclophosphamide and betamethasone gives quicker, better and more durable response than VAD/CyBet regimens: results from a Swedish retrospective analysis.
Katarina Uttervall, Johannes Admasie, Evren Alici, Johan Lund, Johan Liwing

Acta Haematol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective.
John Hornberger, Joseph Rickert, Ravinder Dhawan, Johan Liwing, Johan Aschan

Eur J Haematol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sickness absence and concurrent low back and neck-shoulder pain: results from the MUSIC-Norrtälje study.
Teresia Nyman, Wilhelmus Johannes Andreas Grooten, Christina Wiktorin, Johan Liwing, Linda Norrman

Eur Spine J· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis